Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rik Schoemaker

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
CPT: Pharmacometrics & Systems Pharmacology|June 18, 2019
Nonlinear Mixed-Effects Model Development and Simulation Using nlmixr and Related R Open-Source PackagesMatthew Fidler, Justin J Wilkins, Richard Hooijmaijers, et al.
British Journal of Clinical Pharmacology|August 7, 2024
Model-based comparisons of post-treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European UnionRui Zhu, Rik Schoemaker, Aurelie Gautier, et al.
British Journal of Clinical Pharmacology|August 27, 2005
Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modellingSerge Cremers, Rik Schoemaker, Eduard Scholten, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 4, 2019
Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumorsLene Alifrangis, Rik Schoemaker, Niels J Skartved, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 27, 2019
Performance of the SAEM and FOCEI Algorithms in the Open-Source, Nonlinear Mixed Effect Modeling Tool nlmixrRik Schoemaker, Matthew Fidler, Christian Laveille, et al.
British Journal of Clinical Pharmacology|September 26, 2006
Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteersMartijn van Doorn, Michiel Kemme, Margriet Ouwens, et al.
Epilepsia|October 24, 2025
Pharmacokinetics and tolerability of single-dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescentsPavel Klein, Gewalin Aungaroon, Victor Biton, et al.
Pulmonary Pharmacology & Therapeutics|September 30, 2021
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polypsRui Zhu, Ryan Owen, Justin Wilkins, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
CPT: Pharmacometrics & Systems Pharmacology|June 18, 2019
Nonlinear Mixed-Effects Model Development and Simulation Using nlmixr and Related R Open-Source PackagesMatthew Fidler, Justin J Wilkins, Richard Hooijmaijers, et al.
British Journal of Clinical Pharmacology|August 7, 2024
Model-based comparisons of post-treatment free IgE and FEV1 between omalizumab asthma dosing tables in the United States and European UnionRui Zhu, Rik Schoemaker, Aurelie Gautier, et al.
British Journal of Clinical Pharmacology|August 27, 2005
Characterizing the role of enterohepatic recycling in the interactions between mycophenolate mofetil and calcineurin inhibitors in renal transplant patients by pharmacokinetic modellingSerge Cremers, Rik Schoemaker, Eduard Scholten, et al.
Journal of Pharmacokinetics and Pharmacodynamics|November 4, 2019
Population pharmacokinetics and covariate analysis of Sym004, an antibody mixture against the epidermal growth factor receptor, in subjects with metastatic colorectal cancer and other solid tumorsLene Alifrangis, Rik Schoemaker, Niels J Skartved, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 27, 2019
Performance of the SAEM and FOCEI Algorithms in the Open-Source, Nonlinear Mixed Effect Modeling Tool nlmixrRik Schoemaker, Matthew Fidler, Christian Laveille, et al.
British Journal of Clinical Pharmacology|September 26, 2006
Evaluation of proinflammatory cytokines and inflammation markers as biomarkers for the action of thiazolidinediones in Type 2 diabetes mellitus patients and healthy volunteersMartijn van Doorn, Michiel Kemme, Margriet Ouwens, et al.
Epilepsia|October 24, 2025
Pharmacokinetics and tolerability of single-dose Staccato® alprazolam in adolescents with epilepsy, and population pharmacokinetic analysis to support dose selection in adolescentsPavel Klein, Gewalin Aungaroon, Victor Biton, et al.
Pulmonary Pharmacology & Therapeutics|September 30, 2021
Pharmacokinetics and exposure-efficacy relationships of omalizumab in patients with nasal polypsRui Zhu, Ryan Owen, Justin Wilkins, et al.
Pageof 2